These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16984137)

  • 1. Polyvalent inhibitors of anthrax toxin that target host receptors.
    Basha S; Rai P; Poon V; Saraph A; Gujraty K; Go MY; Sadacharan S; Frost M; Mogridge J; Kane RS
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13509-13. PubMed ID: 16938891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidotes to anthrax lethal factor intoxication. Part 1: Discovery of potent lethal factor inhibitors with in vivo efficacy.
    Jiao GS; Kim S; Moayeri M; Cregar-Hernandez L; McKasson L; Margosiak SA; Leppla SH; Johnson AT
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6850-3. PubMed ID: 20864339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium chloride enhanced oligomerization of L-glutamic acid in aqueous solution.
    Wang KJ; Yao N; Li C
    Orig Life Evol Biosph; 2005 Aug; 35(4):313-22. PubMed ID: 16228645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of multivalent polymer-aptamer conjugates with enhanced inhibitory potency.
    Martin JT; Douaisi M; Arsiwala A; Arha M; Kane RS
    Int J Nanomedicine; 2018; 13():5249-5253. PubMed ID: 30237711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent Inhibitors of Channel-Forming Bacterial Toxins.
    Yamini G; Nestorovich EM
    Curr Top Microbiol Immunol; 2017; 406():199-227. PubMed ID: 27469304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric drugs: Advances in the development of pharmacologically active polymers.
    Li J; Yu F; Chen Y; Oupický D
    J Control Release; 2015 Dec; 219():369-382. PubMed ID: 26410809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic PAMAM dendrimers as pore-blocking binary toxin inhibitors.
    Förstner P; Bayer F; Kalu N; Felsen S; Förtsch C; Aloufi A; Ng DY; Weil T; Nestorovich EM; Barth H
    Biomacromolecules; 2014 Jul; 15(7):2461-74. PubMed ID: 24954629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructing toxin pathways by targeted pore blockage.
    Nestorovich EM; Bezrukov SM
    Chem Rev; 2012 Dec; 112(12):6388-430. PubMed ID: 23057504
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-based design of a heptavalent anthrax toxin inhibitor.
    Joshi A; Kate S; Poon V; Mondal D; Boggara MB; Saraph A; Martin JT; McAlpine R; Day R; Garcia AE; Mogridge J; Kane RS
    Biomacromolecules; 2011 Mar; 12(3):791-6. PubMed ID: 21302959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Homopolymers and Copolymers Containing an Active Ester of Acrylic Acid by RAFT: Scaffolds for Controlling Polyvalent Ligand Display.
    Gujraty KV; Yanjarappa MJ; Saraph A; Joshi A; Mogridge J; Kane RS
    J Polym Sci A Polym Chem; 2008 Sep; 46(21):7246-7257. PubMed ID: 19855852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable and potent polyvalent anthrax toxin inhibitors: raft-inspired domain formation in liposomes that contain PEGylated lipids.
    Rai P; Vance D; Poon V; Mogridge J; Kane RS
    Chemistry; 2008; 14(26):7748-51. PubMed ID: 18666271
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins.
    Rai P; Padala C; Poon V; Saraph A; Basha S; Kate S; Tao K; Mogridge J; Kane RS
    Nat Biotechnol; 2006 May; 24(5):582-6. PubMed ID: 16633350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of peptide-based anthrax toxin inhibitors.
    Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
    Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
    Mourez M; Collier RJ
    Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ins and Outs of Anthrax Toxin.
    Friebe S; van der Goot FG; Bürgi J
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26978402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.
    Joshi A; Saraph A; Poon V; Mogridge J; Kane RS
    Bioconjug Chem; 2006; 17(5):1265-9. PubMed ID: 16984137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of polyvalent inhibitors of controlled molecular weight: structure-activity relationship for inhibitors of anthrax toxin.
    Gujraty KV; Joshi A; Saraph A; Poon V; Mogridge J; Kane RS
    Biomacromolecules; 2006 Jul; 7(7):2082-5. PubMed ID: 16827573
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.